{"schema_version":"secwatch.filing_event.v1","accession":"0001816590-22-000014","form_type":"8-K","ticker":"CMPS","cik":"0001816590","company_name":"COMPASS Pathways plc","filed_at":"2022-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.392590+00:00","generated_at":"2026-06-26T17:37:00.523920+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"COMPASS Pathways establishes The Centre for Mental Health Research and Innovation with King's College London and SLaM","bullets":["Up to £12M investment over 10-year term; Centre to accelerate psychedelic therapy research and new care models.","Initial focus on COMP360 psilocybin therapy for TRD, PTSD, and anorexia nervosa; expects 650-700 patients over 5 years.","Facilities to be built at Bethlem Royal Hospital in London; state-of-the-art clinical trial space.","Partnership with UK's largest NHS mental health trust (SLaM) and King's College London's IoPPN."],"urls":{"canonical":"https://secwatch.observer/filing/0001816590-22-000014","json":"https://secwatch.observer/filing/0001816590-22-000014.json","markdown":"https://secwatch.observer/filing/0001816590-22-000014.md","text":"https://secwatch.observer/filing/0001816590-22-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000014/0001816590-22-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000014/cmps-20220324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T17:37:00.523920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}